Expression of chimeric human transferrin-chloramphenicol acetyltransferase genes in liver and brain of transgenic mice during development

Yan Lu, Laura A. Cox, Damon C. Herbert, Frank J. Weaker, Christi A Walter, Gwen S. Adrian

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Transferrin (TF) gene expression is tissue specific and is regulated during development. Transgenic mice have been developed which carry 1.2 or 0.67 kb of the TF 5′ flanking region of the human TF gene fused to the bacterial chloramphenicol acetyltramferase (CAT) gene. The onset of expression of the chimeric human TF-CAT transgenes in liver and brain during development has been studied in these transgenic mice. In brain, the TF(0.67)CAT transgene began to express between 5 and 10 days after birth; in liver, the TF(0.67)CAT transgene was turned on between 10 and 20 days after birth. Endogenous mouse TF mRNA levels in liver and brain have also been measured during development by Northern analysis. In brain, the developmental expression pattern of the TF(0.67)CAT transgene is the same as the mouse endogenous TF gene; in liver, the transgene is turned on later than the endogenous mouse TF gene. DNA-protein mobility shift assays and DNase I footprinting analyses were conducted in the region of -621 to -409 bp of the human TF gene by using TF-CAT expressing liver nuclear extract from 27-day-old mice and nonexpressing liver nuclear extract from 7-day-old mice. The level of protein-DNA complex formation is several times higher in the expressing extracts, and the region from -481 to -463 bp of human TF gene is protected by the expressing extract but not the nonexpressing extracts. As demonstrated by this and other studies, the transgenic mouse model furnishes a unique opportunity to analyze developmental regulation of human transgenes.

Original languageEnglish (US)
Pages (from-to)452-458
Number of pages7
JournalDevelopmental Biology
Volume155
Issue number2
StatePublished - 1993

Fingerprint

Chloramphenicol O-Acetyltransferase
Transferrin
Transgenic Mice
Liver
Brain
Chloramphenicol
Transgenes
Genes
Liver Extracts
Parturition
5' Flanking Region
Deoxyribonuclease I
DNA
Electrophoretic Mobility Shift Assay
Proteins

ASJC Scopus subject areas

  • Developmental Biology

Cite this

Expression of chimeric human transferrin-chloramphenicol acetyltransferase genes in liver and brain of transgenic mice during development. / Lu, Yan; Cox, Laura A.; Herbert, Damon C.; Weaker, Frank J.; Walter, Christi A; Adrian, Gwen S.

In: Developmental Biology, Vol. 155, No. 2, 1993, p. 452-458.

Research output: Contribution to journalArticle

Lu, Yan ; Cox, Laura A. ; Herbert, Damon C. ; Weaker, Frank J. ; Walter, Christi A ; Adrian, Gwen S. / Expression of chimeric human transferrin-chloramphenicol acetyltransferase genes in liver and brain of transgenic mice during development. In: Developmental Biology. 1993 ; Vol. 155, No. 2. pp. 452-458.
@article{8c64c7e764da4d20a7fddfb8db5c9ba7,
title = "Expression of chimeric human transferrin-chloramphenicol acetyltransferase genes in liver and brain of transgenic mice during development",
abstract = "Transferrin (TF) gene expression is tissue specific and is regulated during development. Transgenic mice have been developed which carry 1.2 or 0.67 kb of the TF 5′ flanking region of the human TF gene fused to the bacterial chloramphenicol acetyltramferase (CAT) gene. The onset of expression of the chimeric human TF-CAT transgenes in liver and brain during development has been studied in these transgenic mice. In brain, the TF(0.67)CAT transgene began to express between 5 and 10 days after birth; in liver, the TF(0.67)CAT transgene was turned on between 10 and 20 days after birth. Endogenous mouse TF mRNA levels in liver and brain have also been measured during development by Northern analysis. In brain, the developmental expression pattern of the TF(0.67)CAT transgene is the same as the mouse endogenous TF gene; in liver, the transgene is turned on later than the endogenous mouse TF gene. DNA-protein mobility shift assays and DNase I footprinting analyses were conducted in the region of -621 to -409 bp of the human TF gene by using TF-CAT expressing liver nuclear extract from 27-day-old mice and nonexpressing liver nuclear extract from 7-day-old mice. The level of protein-DNA complex formation is several times higher in the expressing extracts, and the region from -481 to -463 bp of human TF gene is protected by the expressing extract but not the nonexpressing extracts. As demonstrated by this and other studies, the transgenic mouse model furnishes a unique opportunity to analyze developmental regulation of human transgenes.",
author = "Yan Lu and Cox, {Laura A.} and Herbert, {Damon C.} and Weaker, {Frank J.} and Walter, {Christi A} and Adrian, {Gwen S.}",
year = "1993",
language = "English (US)",
volume = "155",
pages = "452--458",
journal = "Developmental Biology",
issn = "0012-1606",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Expression of chimeric human transferrin-chloramphenicol acetyltransferase genes in liver and brain of transgenic mice during development

AU - Lu, Yan

AU - Cox, Laura A.

AU - Herbert, Damon C.

AU - Weaker, Frank J.

AU - Walter, Christi A

AU - Adrian, Gwen S.

PY - 1993

Y1 - 1993

N2 - Transferrin (TF) gene expression is tissue specific and is regulated during development. Transgenic mice have been developed which carry 1.2 or 0.67 kb of the TF 5′ flanking region of the human TF gene fused to the bacterial chloramphenicol acetyltramferase (CAT) gene. The onset of expression of the chimeric human TF-CAT transgenes in liver and brain during development has been studied in these transgenic mice. In brain, the TF(0.67)CAT transgene began to express between 5 and 10 days after birth; in liver, the TF(0.67)CAT transgene was turned on between 10 and 20 days after birth. Endogenous mouse TF mRNA levels in liver and brain have also been measured during development by Northern analysis. In brain, the developmental expression pattern of the TF(0.67)CAT transgene is the same as the mouse endogenous TF gene; in liver, the transgene is turned on later than the endogenous mouse TF gene. DNA-protein mobility shift assays and DNase I footprinting analyses were conducted in the region of -621 to -409 bp of the human TF gene by using TF-CAT expressing liver nuclear extract from 27-day-old mice and nonexpressing liver nuclear extract from 7-day-old mice. The level of protein-DNA complex formation is several times higher in the expressing extracts, and the region from -481 to -463 bp of human TF gene is protected by the expressing extract but not the nonexpressing extracts. As demonstrated by this and other studies, the transgenic mouse model furnishes a unique opportunity to analyze developmental regulation of human transgenes.

AB - Transferrin (TF) gene expression is tissue specific and is regulated during development. Transgenic mice have been developed which carry 1.2 or 0.67 kb of the TF 5′ flanking region of the human TF gene fused to the bacterial chloramphenicol acetyltramferase (CAT) gene. The onset of expression of the chimeric human TF-CAT transgenes in liver and brain during development has been studied in these transgenic mice. In brain, the TF(0.67)CAT transgene began to express between 5 and 10 days after birth; in liver, the TF(0.67)CAT transgene was turned on between 10 and 20 days after birth. Endogenous mouse TF mRNA levels in liver and brain have also been measured during development by Northern analysis. In brain, the developmental expression pattern of the TF(0.67)CAT transgene is the same as the mouse endogenous TF gene; in liver, the transgene is turned on later than the endogenous mouse TF gene. DNA-protein mobility shift assays and DNase I footprinting analyses were conducted in the region of -621 to -409 bp of the human TF gene by using TF-CAT expressing liver nuclear extract from 27-day-old mice and nonexpressing liver nuclear extract from 7-day-old mice. The level of protein-DNA complex formation is several times higher in the expressing extracts, and the region from -481 to -463 bp of human TF gene is protected by the expressing extract but not the nonexpressing extracts. As demonstrated by this and other studies, the transgenic mouse model furnishes a unique opportunity to analyze developmental regulation of human transgenes.

UR - http://www.scopus.com/inward/record.url?scp=0027466336&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027466336&partnerID=8YFLogxK

M3 - Article

C2 - 8432399

AN - SCOPUS:0027466336

VL - 155

SP - 452

EP - 458

JO - Developmental Biology

JF - Developmental Biology

SN - 0012-1606

IS - 2

ER -